1. Home
  2. KPLT vs NTRB Comparison

KPLT vs NTRB Comparison

Compare KPLT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Katapult Holdings Inc.

KPLT

Katapult Holdings Inc.

HOLD

Current Price

$5.04

Market Cap

39.2M

ML Signal

HOLD

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$8.00

Market Cap

72.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPLT
NTRB
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.2M
72.6M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
KPLT
NTRB
Price
$5.04
$8.00
Analyst Decision
Hold
Analyst Count
1
0
Target Price
★ $10.00
N/A
AVG Volume (30 Days)
★ 230.5K
98.2K
Earning Date
05-07-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 98.15
N/A
EPS
N/A
★ N/A
Revenue
★ $291,761,000.00
$2,036,651.00
Revenue This Year
$18.62
$30.17
Revenue Next Year
$15.34
$3,394.36
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 18.03
N/A
52 Week Low
$5.30
$2.80
52 Week High
$17.45
$9.00

Technical Indicators

Market Signals
Indicator
KPLT
NTRB
Relative Strength Index (RSI) 30.73 65.16
Support Level N/A $3.68
Resistance Level $7.25 N/A
Average True Range (ATR) 0.88 0.97
MACD -0.42 0.08
Stochastic Oscillator 4.85 69.53

Price Performance

Historical Comparison
KPLT
NTRB

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: